PET instrumentation: What are the limits?
- 作者Thomas F. Budinger
- 卷第28卷
- 期第3期
- 印刷ISSN0001-2998
- 文件大小4918.73KB
- 发表时间1998
- DOI10.1016/s0001-2998(98)80030-5
<i>Update</i> Palliative Therapy with Bone Seeking RadiopharmaceuticalsMcEwan, A.J.B. · Cancer Biotherapy & Radiopharmaceuticals · 1998
Use of radionuclides for the palliation of bone metastasesA.J.B. McEwan · 2000
320. A SPECT study of gender and striatal dopamineD.M. Li; P. Chokka; A.J.B. McEwan; W. Logus; S. Mantei; J. Hanson; P. Tibbo · 2000
Cyclotron production of 99mTc: Recycling of enriched 100Mo metal targetsK. Gagnon; J.S. Wilson; C.M.B. Holt; D.N. Abrams; A.J.B. McEwan; D. Mitlin; S.A. McQuarrie · 2012
Analysis of intraprostatic therapeutic effects in prostate cancer patients using [11C]-choline PET/CT after external-beam radiation therapyAmanie, J.; Jans, H.S.; Wuest, M.; Pervez, N.; Murtha, A.; Usmani, N.; Yee, D.; Pearcey, R.; Danielson, B.; Patel, S.; Macewan, R.; Field, C.; Robinson, D.; Wilson, J.; Lewis, D.; Parliament, M.; McEwan, A.J.B. · Current Oncology · 2013
A Phase II Study of Submandibular Gland Transfer Prior to Radiation for Prevention of Radiation-induced Xerostomia in Head-and-Neck Cancer (RTOG 0244)Naresh Jha; Jonathan Harris; Hadi Seikaly; John R. Jacobs; A.J.B. McEwan; K. Thomas Robbins; John Grecula; Anand K. Sharma; K. Kian Ang · 2012
Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancerA.T. Porter; A.J.B. McEwan; J.E. Powe; R. Reid; D.G. McGowan; H. Lukka; J.R. Sathyanarayana; V.N. Yakemchuk; G.M. Thomas; L.E. Erlich; J. Crook; K.Y. Gulenchyn; K.E. Hong; C. Wesolowski; J. Yardley · 1993